Increasingly individuals are hearing about Wegovy and other GLP-1 therapies due to their apparent impact in slimming . Initially designed to manage diabetes , these GLP-1 receptor agonists work by replicating a body's compound that influences food intake and delays gastric motility . This two-pronged approach can result in noticeable slimming for